查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1714628

基因组学市场（按产品、技术、类型、应用和最终用户划分）—2025 年至 2030 年全球预测

Genomics Market by Offering, Technology, Type, Applications, End Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计基因组学市场规模在 2024 年将达到 522.2 亿美元，到 2025 年将以 9.78% 的复合年增长率增长至 571.5 亿美元，到 2030 年将达到 914.5 亿美元。

主要市场统计数据
基准年2024年 522.2亿美元
预计年份：2025年 571.5亿美元
预测年份 2030 914.5亿美元
复合年增长率（%） 9.78%

近年来，基因组学产业经历了重大变革，推动力来自突破性的技术进步以及对健康和疾病遗传机制的深入了解。创新方法和新设备的快速整合不仅重新定义了研究范式，也重新定义了临床应用。该报告对基因组学生态系统进行了深入的概述，详细介绍了市场动态、细分、区域影响以及在该领域树立新标竿的主要企业。

研究和商业性利益之间的持续相互作用正在加速发现的步伐。产业相关人员发现自己正处于传统技术和根本性创新的十字路口，这些创新正在为个人化医疗、作物开发和药物发现铺平新的道路。基因组研究的进步有助于改善诊断和治疗方法，最终改变患者照护并扩大商业机会。随着研究机构、医院、製药和相关企业整合这些进步，这些变革性创新的影响变得越来越明显。

此外，市场力量和消费者需求之间的相互作用正在刺激对技术和基础设施的投资。透过利用尖端定序技术和先进的生物资讯学，各组织正在为更精确、更有效的治疗铺平道路。科学突破与策略倡议的融合预示着快速发展，有望带来显着成长。下面，我们概述了这一行业转变的关键方面、对细分的详细见解以及提供全球基因组趋势细緻入微的观点的区域差异。

影响基因体学的变革

基因组学市场最近的转型变化反映了技术突破、不断变化的监管环境以及相关人员优先事项的变化。自动化、小型化和整合数据分析的进步重塑了实验室工作流程和业务效率。定序技术和仪器的新发展实现了以前难以想像的精度和可扩展性水平。

下一代定序平台、数位 PCR 的增强以及不断扩展的多路復用能力等技术创新共同促成了一种速度、准确性和成本效益不可妥协的范式。同时，我们也对研发进行了投资，以继续推动生物资讯学和湿实验室流程的整合。由于样品製备的改进和分析方法的复杂化，实验室现在可以非常清晰地揭示复杂的基因突变和表观遗传修饰。

此外，不断发展的监管政策和加强的公私合作在简化产品开发和加速临床测试方面发挥着至关重要的作用。这些合作带来了更多的资金筹措、策略伙伴关係以及相关人员之间的共用愿景：基因组学的未来在于创新主导、以患者为中心的解决方案。人工智慧和机器学习的整合以处理庞大的数据集也正在成为改善诊断和开发标靶治疗的关键驱动力。

总的来说，这些变革性的变化正在推动基因组学产业进入多方面研究与实际应用整合的新领域。技术创新的步伐不断加快，预示着基因组学的科学和商业将重新定义美好的未来。

基因组学市场的详细细分见解

基因组学市场的細項分析提供了对不同产品、技术、分析类型、应用和用户细分的多层次理解。市场综合研究根据产品、技术、类型、应用和最终用户进行细分。例如，在产品类别中，市场细分为消耗品、设备和服务。耗材进一步分为套件、检测试剂和试剂，而设备则分为分析仪和定序仪。这种结构不仅可以实现明确的产品差异化，还可以突显市场内不同的收益来源。

在技​​术细分方面，重点转向基因编辑、微阵列、PCR和定序技术的演化。基因编辑技术已针对 CRISPR/Cas9、TALEN 和锌指核酸酶进行了评估，微阵列技术已通过研究细胞微阵列、DNA 微阵列和蛋白质微阵列得到改进，PCR 技术已细分为数字 PCR、终点 PCR 和即时PCR，定序技术已经过严格的分析，涵盖下一代、桑格和第三代定序方法。这种差异化有助于产业领导者识别成长领域、潜在投资目标和研究趋势。

根据基因组分析类型，另一种细分包括表观基因、功能基因组学、药物基因组学和结构基因组学。这种分类对于使市场产品与特定的科学和临床目标保持一致、优化研究重点和资源分配至关重要。此外，基于应用的细分涵盖动物遗传学、作物开发、诊断、药物发现和开发、个人化医疗以及研究和开发。每个应用都呈现出独特的挑战和机会，为技术进步最有可能带来显着成果的细分领域提供了洞察。

最后，最终用户细分提供了农业相关企业、医院诊所、製药和生物技术公司以及研究机构的市场部署的详细视角。农业综合企业业务部门进一步细分为畜牧公司和种苗公司，突显了农业遗传学和作物开发方面的专业要求和独特的市场动态。这种结构化的细分不仅能更了解当前的市场趋势，还能使相关人员为各自的业务部门制定专门的策略。

这些细分的见解为策略规划和投资决策提供了坚实的基础。每个领域都有其独特的机会和挑战，全面的分析可以作为应对日益动态的市场复杂性的蓝图。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 全球遗传疾病盛行率不断上升
      • 精准医疗和个人化照护日益成为趋势
      • 基因组学在农业和法医学的应用扩展
    • 限制因素
      • 与测试中使用的遗传多样性评估相关的担忧
    • 机会
      • 整合人工智慧和先进的生物资讯学，实现基因组数据分析的自动化和增强
      • 政府和私人组织增加基因组学研究和开发的资金和津贴
    • 任务
      • 缺乏标准化方法降低了基因组学领域实施的效率
  • 市场区隔分析
    • 提供：提高基因组学分析仪器在诊断和了解遗传疾病方面的相关性
    • 技术：精准、高效、多功能扩展了 CRISPR/Cas9 的应用范围
    • 类型：功能基因组学在确定基因组成之间的复杂关係方面的优势日益增强
    • 应用：扩大基因组学在动物遗传学的应用，以提高抗病性和活力
    • 最终用户：种子公司采用新基因组学开发产量作物品种
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

6. 基因组学市场（依产品提供）

  • 介绍
  • 耗材
    • 套件和检测试剂
    • 试剂
  • 装置
    • 分析仪
    • 序列器
  • 服务

第七章 基因组学市场（按技术）

  • 介绍
  • 基因编辑技术
    • CRISPR/Cas9
    • TALENs
    • 锌指核酸酶
  • 微阵列技术
    • 细胞微阵列
    • DNA微阵列
    • 蛋白质微阵列
  • PCR技术
    • 数位PCR
    • 终点PCR
    • 即时PCR
  • 定序技术
    • 下一代定序
    • 桑格定序
    • 第三代定序

第 8 章 基因组学市场（按类型）

  • 介绍
  • 表观基因
  • 功能基因体学
  • 药物基因组学
  • 结构基因体学

第九章 基因组学市场（按应用）

  • 介绍
  • 动物遗传学
  • 作物发育
  • 诊断
  • 药物研发
  • 个人化医疗
  • 研究与开发

第 10 章 基因组学市场（按最终用户划分）

  • 介绍
  • 农业业务
    • 畜牧公司
    • 种子公司
  • 医院和诊所
  • 製药和生物技术公司
  • 研究所

第 11 章：美洲基因体学市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

12.亚太基因组学市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

13. 欧洲、中东和非洲基因体学市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十四章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • 10x Genomics, Inc.
  • 23andMe Holding Co.
  • Agilent Technologies, Inc.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Centogene NV
  • EPIC Sciences, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare（Now Cytiva）by Danaher Corporation
  • Gencove, Inc.
  • GenScript BIoTech Corporation
  • Guardant Health, Inc.
  • Helix OpCo, LLC
  • Illumina, Inc.
  • Invitae Corporation
  • Merck & Co., Inc.
  • Myriad Genetics Laboratories, Inc.
  • Natera, Inc.
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California, Inc.
  • Personalis, Inc.
  • Quest Diagnostics
  • SomaLogic, Inc.
  • Sophia Genetics SA
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
Product Code: MRR-434CCDA04CD1

The Genomics Market was valued at USD 52.22 billion in 2024 and is projected to grow to USD 57.15 billion in 2025, with a CAGR of 9.78%, reaching USD 91.45 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 52.22 billion
Estimated Year [2025] USD 57.15 billion
Forecast Year [2030] USD 91.45 billion
CAGR (%) 9.78%

In recent years, the genomics industry has undergone a significant evolution fueled by groundbreaking technological advancements and a deepening understanding of genetic mechanisms that drive both health and disease. The rapid integration of innovative methodologies and novel instrumentation has redefined not only research paradigms but also clinical applications. This document provides an insightful overview of the genomics ecosystem, detailing market dynamics, segmentation, regional influences, and the leading companies that are setting new benchmarks in the field.

The continuous interplay of research and commercial interests has accelerated the pace of discovery. Industry stakeholders are finding themselves at the crossroads of traditional techniques and radical innovations that open new avenues for personalized medicine, crop development, and drug discovery. The evolution of genomic research has also contributed to the refinement of diagnostics alongside therapeutic advancements, ultimately transforming patient care while expanding the opportunities for commercialization. As research institutions, hospitals, and companies engaged in pharmaceutical and biotechnology integrate these advancements, the impact of such transformative innovations is increasingly visible.

Furthermore, the interplay between market forces and consumer demand has stimulated investments in both technology and infrastructure. By harnessing state-of-the-art sequencing techniques and advanced bioinformatics, organizations have paved the way for more precise and efficient therapies. This landscape, marked by rapid development, promises substantial growth driven by a confluence of scientific breakthroughs and strategic initiatives. The narrative that follows outlines key aspects of these industry shifts, detailed segmentation insights, and the regional variations that provide a nuanced perspective on global genomics trends.

Transformative Changes Impacting Genomics

Recent transformative shifts in the genomics market reflect a convergence of technological breakthroughs, evolving regulatory landscapes, and shifting stakeholder priorities. Advancements in automation, miniaturization, and integrated data analytics have reimagined laboratory workflows and operational efficiencies. New developments in sequencing technologies and instrumentation have enabled a level of precision and scalability that was previously unimaginable.

Technological innovations such as next-generation sequencing platforms, digital PCR enhancements, and extended multiplexing capabilities have collectively contributed to a paradigm where speed, accuracy, and cost-effectiveness are non-negotiable. This is complemented by investments in research and development, which continue to drive the convergence of bioinformatics with wet-lab processes. With improved sample preparations and high-throughput analytical methods, laboratories can now uncover complex genetic variations and epigenetic modifications with remarkable clarity.

Further, evolving regulatory policies and increased collaboration across public and private sectors have played a pivotal role in streamlining product development and expediting clinical trials. Such collaboration has led to enhanced funding, strategic partnerships, and a shared vision among stakeholders that the future of genomics rests on innovation-driven, patient-centric solutions. The integration of artificial intelligence and machine learning to process massive data sets has also emerged as a key factor in refining diagnostics and developing targeted therapies.

Overall, these transformative shifts are pushing the genomics industry into new realms where multidimensional research converges with practical applications. The pace of innovation continues to accelerate, signaling a promising future that redefines both the science and business of genomics.

Detailed Segmentation Insights in Genomics Market

The segmentation analysis of the genomics market provides a multilayered understanding of diverse offerings, technologies, analytical types, applications, and user demographics. A comprehensive study of the market is segmented based on offering, technology, type, applications, and end users. For instance, in the offering category, the market is segmented into consumables, instruments, and service. Within consumables, the analysis further distinguishes between kits and assays and reagents, while instruments are reviewed through the lens of analyzers and sequencers. This structure not only clarifies product differentiation but also highlights distinct revenue streams within the market.

Regarding technological segmentation, the focus shifts to the evolution of gene editing techniques, microarray technology, PCR technology, and sequencing technology. Each of these sub-segments is dissected to reveal further insights: gene editing techniques are evaluated with respect to CRISPR/Cas9, TALENs, and zinc finger nucleases; microarray technology is refined by exploring cellular microarray, DNA microarray, and protein microarray; PCR technology is dissected into digital PCR, end-point PCR, and real-time PCR; sequencing technology undergoes rigorous analysis spanning next-generation, Sanger, and third-generation sequencing methods. Such differentiation assists industry leaders in identifying growth areas, potential investment targets, and research trends.

A separate segmentation based on the type of genomic analysis encompasses epigenomics, functional genomics, pharmacogenomics, and structural genomics. This categorization is critical in aligning market offerings with specific scientific and clinical goals, hence optimizing research focus and resource allocation. Moreover, application-based segmentation spans animal genetics, crop development, diagnostics, drug discovery and development, personalized medicine, and research and development. Each application provides unique challenges and opportunities, giving insight into niches where technological advancement is most likely to yield significant results.

Finally, the segmentation based on end users offers a detailed perspective on market deployment across agribusiness, hospitals and clinics, pharmaceutical and biotechnology companies, and research institutes. The agribusiness segment, further delineated into livestock companies and seed companies, underscores the specialized requirements and unique market dynamics in agricultural genetics and crop development. This structured segmentation not only enriches the understanding of current market trends but also enables stakeholders to tailor strategies specifically to their area of operation.

Taken together, these segmented insights provide a strong foundation for strategic planning and investment decisions. With each segment presenting its own set of opportunities and challenges, the comprehensive analysis serves as a roadmap for navigating the complexities of an increasingly dynamic market.

Based on Offering, market is studied across Consumables, Instruments, and Service. The Consumables is further studied across Kits & Assays and Reagents. The Instruments is further studied across Analyzers and Sequencers.

Based on Technology, market is studied across Gene Editing Technique, Microarray Technology, PCR Technology, and Sequencing Technology. The Gene Editing Technique is further studied across CRISPR/Cas9, TALENs, and Zinc Finger Nucleases. The Microarray Technology is further studied across Cellular Microarray, DNA Microarray, and Protein Microarray. The PCR Technology is further studied across Digital PCR, End-Point PCR, and Real-Time PCR. The Sequencing Technology is further studied across Next-Generation Sequencing, Sanger Sequencing, and Third-Generation Sequencing.

Based on Type, market is studied across Epigenomics, Functional Genomics, Pharmacogenomics, and Structural Genomics.

Based on Applications, market is studied across Animal Genetics, Crop Development, Diagnostics, Drug Discovery & Development, Personalized Medicine, and Research & Development.

Based on End Users, market is studied across Agribusiness, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Institutes. The Agribusiness is further studied across Livestock Companies and Seed Companies.

Regional Market Dynamics in a Global Perspective

Global analysis of the genomics market reveals significant regional variations that underline the international pace of innovation and investment. The dynamics in the Americas are marked by advanced research infrastructure, strong investment in biotechnology, and a robust clinical application environment. In contrast, the landscape in Europe, the Middle East, and Africa exhibits rapid adjustments to technological advancements with rising public-private collaborations. Asia-Pacific, meanwhile, continues to demonstrate impressive growth spearheaded by large-scale government initiatives and rapid industrialization, driving innovation and competitive pricing across the market.

These regional insights highlight that while technological and research advancements serve as universal catalysts, local policy frameworks, funding mechanisms, and market readiness differ greatly. Consequently, each region presents unique investment opportunities and specific challenges tailored to their economic and regulatory contexts.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Companies Driving Genomics Innovation

The competitive landscape is characterized by a plethora of key companies that are at the forefront of innovation in the genomics sector. Innovators such as 10x Genomics, Inc. and 23andMe Holding Co. have pioneered platforms that push the boundaries of what is possible in DNA analysis and personalized health insights. Agilent Technologies, Inc. and BGI Genomics Co., Ltd. continue to set high standards in instrument and consumables development, enabling more efficient and expansive analyses. Companies like Bio-Rad Laboratories, Inc. and Centogene N.V. have furthered the field with innovations in assay development and diagnostic capabilities.

Other industry leaders including EPIC Sciences, Inc. and Eurofins Scientific SE underscore the critical role of comprehensive service solutions in driving market adoption. In addition, global entities such as F. Hoffmann-La Roche Ltd. and GE Healthcare (Now Cytiva) by Danaher Corporation have successfully integrated robust R&D with high-quality manufacturing processes, leading to a consistent track record of product reliability. Organizations like Gencove, Inc. and GenScript Biotech Corporation contribute to high-throughput sequencing and gene synthesis respectively, amplifying the reach of genomic technologies.

Leading innovators such as Guardant Health, Inc. and Helix OpCo, LLC have carved niches in clinical diagnostics and data analytics, while renowned firms including Illumina, Inc., Invitae Corporation, and Merck & Co., Inc. continue to lead in research and innovation fronts. The strategic focus of organizations such as Myriad Genetics Laboratories, Inc., Natera, Inc., and Oxford Nanopore Technologies PLC illustrates the sector's ongoing commitment to pushing technological boundaries. An expanding list of influential companies including Pacific Biosciences of California, Inc., Personalis, Inc., and Quest Diagnostics further cement the competitive spirit within this fast-evolving market. The leadership of SomaLogic, Inc., Sophia Genetics SA, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation rounds out a vibrant ecosystem that is continuously reinventing the ways in which genomics is applied for research, diagnostics, and therapeutic innovation.

The collective force of these companies contributes significantly to setting industry standards, driving forward technological innovations, and fostering partnerships that help overcome traditional industry challenges. Their ongoing investment in research and development, global expansion, and commitment to cutting-edge quality and service methodologies ensure that the genomics sector remains dynamic and poised for future growth.

The report delves into recent significant developments in the Genomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., 23andMe Holding Co., Agilent Technologies, Inc., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Centogene N.V., EPIC Sciences, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., GE Healthcare (Now Cytiva) by Danaher Corporation, Gencove, Inc., GenScript Biotech Corporation, Guardant Health, Inc., Helix OpCo, LLC, Illumina, Inc., Invitae Corporation, Merck & Co., Inc., Myriad Genetics Laboratories, Inc., Natera, Inc., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., Personalis, Inc., Quest Diagnostics, SomaLogic, Inc., Sophia Genetics SA, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation. Actionable Strategies for Future Industry Success

For industry leaders seeking to secure competitive advantages in the evolving genomics landscape, it is essential to harness technological innovations and streamline operational processes. Prioritizing investments in advanced sequencing technologies, data analytics, and artificial intelligence integration can offer a leap in research capabilities. Leaders are encouraged to foster strategic collaborations that combine academic research with corporate innovation, thereby expanding access to state-of-the-art laboratory facilities and expertise.

Investing in training programs that keep staff updated with the latest technological trends and regulatory updates will further enhance operational efficiency. Integrating flexible business models that can quickly adapt to market trends is equally vital. Moreover, leveraging comprehensive market intelligence and detailed segmentation insights assists in tailoring solutions to meet specific customer requirements while optimizing resource allocation and scaling operations effectively. These proactive initiatives create a robust foundation that not only drives growth but also nurtures innovation in a competitive marketplace.

Final Thoughts on the Genomics Market Evolution

The genomics market continues to demonstrate resilience and adaptability in an era characterized by rapid technological and scientific advancements. A careful analysis of market drivers, segmentation details, and regional variances reveals an industry committed to innovation and sustainability. With a broad spectrum of offerings that range from consumables to sophisticated technologies, the market is well-positioned for sustained growth.

The interplay of collaborative efforts between research institutions, regulatory authorities, and commercial entities paves the way for a future rich in technological breakthroughs and enhanced healthcare outcomes. The continuous evolution of instruments and the diversification of application areas further attest to the sector's dynamic nature. As companies invest in new technologies and embrace cutting-edge analytical methods, the path forward is illuminated by a strategic blend of scientific curiosity and business acumen.

This analysis serves as a robust platform for industry stakeholders looking to understand evolving trends and adapt their strategies accordingly. The careful dissection of market segmentation and the global perspective provided herein underscore the multifaceted opportunities available to those who are agile, forward-thinking, and committed to the pursuit of excellence in genomics.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of genetic disorders globally
      • 5.1.1.2. Growing shift toward precision medicine and personalized therapeutics
      • 5.1.1.3. Expanded application of genomics in agriculture and forensic science
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with assessing genetic diversity used in testings
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of AI and advanced bioinformatics for automating and enhancing genomic data analysis
      • 5.1.3.2. Increased funding and grants for research and development in genomics by governments and private organizations
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardized methodologies reducing efficiency in the genomics field implementation
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering: Higher significance of analyzers in genomics for diagnosing and understanding genetic diseases
    • 5.2.2. Technology: Extending applications of CRISPR/Cas9 owing to precision, efficiency, and versatility
    • 5.2.3. Type: Increasing benefits of functional genomics to determine the complex connection between genetic makeup
    • 5.2.4. Applications: Proliferating adoption of genomics in animal genetics for disease resistance and vitality
    • 5.2.5. End Users: Emerging incorporation of genomics by seed companies to develop high-yield crop varieties
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Genomics Market, by Offering

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Kits & Assays
    • 6.2.2. Reagents
  • 6.3. Instruments
    • 6.3.1. Analyzers
    • 6.3.2. Sequencers
  • 6.4. Service

7. Genomics Market, by Technology

  • 7.1. Introduction
  • 7.2. Gene Editing Technique
    • 7.2.1. CRISPR/Cas9
    • 7.2.2. TALENs
    • 7.2.3. Zinc Finger Nucleases
  • 7.3. Microarray Technology
    • 7.3.1. Cellular Microarray
    • 7.3.2. DNA Microarray
    • 7.3.3. Protein Microarray
  • 7.4. PCR Technology
    • 7.4.1. Digital PCR
    • 7.4.2. End-Point PCR
    • 7.4.3. Real-Time PCR
  • 7.5. Sequencing Technology
    • 7.5.1. Next-Generation Sequencing
    • 7.5.2. Sanger Sequencing
    • 7.5.3. Third-Generation Sequencing

8. Genomics Market, by Type

  • 8.1. Introduction
  • 8.2. Epigenomics
  • 8.3. Functional Genomics
  • 8.4. Pharmacogenomics
  • 8.5. Structural Genomics

9. Genomics Market, by Applications

  • 9.1. Introduction
  • 9.2. Animal Genetics
  • 9.3. Crop Development
  • 9.4. Diagnostics
  • 9.5. Drug Discovery & Development
  • 9.6. Personalized Medicine
  • 9.7. Research & Development

10. Genomics Market, by End Users

  • 10.1. Introduction
  • 10.2. Agribusiness
    • 10.2.1. Livestock Companies
    • 10.2.2. Seed Companies
  • 10.3. Hospitals & Clinics
  • 10.4. Pharmaceutical & Biotechnology Companies
  • 10.5. Research Institutes

11. Americas Genomics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Genomics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Genomics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Novo Holdings acquired Benchmark Genetics for strategic growth and innovation
    • 14.3.2. Solis Agrosciences enhances its genomic solutions with the acquisition of Ferris Genomics expertise and platform
    • 14.3.3. Myriad Genetics partners with Ultima Genomics to enhance clinical tests using UG 100 sequencing
    • 14.3.4. Labcorp expands genetic testing capabilities with strategic acquisition of Invitae's advanced assets in oncology and rare diseases
    • 14.3.5. Labcorp and Ultima Genomics partner to develop oncology testing with advanced genomics technologies
    • 14.3.6. Ambry Genetics and PacBio unite to illuminate rare disease origins through sequencing 7,000 genomes
    • 14.3.7. Variantyx accelerates expansion with USD 36 million investment for advanced genomic testing
    • 14.3.8. SOPHiA GENETICS and Strand Life Sciences joined hands to enhance precision medicine
    • 14.3.9. Nucleus Genomics launched the DNA analysis product to increase the accessibility of whole-genome sequencing
    • 14.3.10. Ultima Genomics introduces UG 100 for affordable, accurate sequencing advancements
  • 14.4. Strategy Analysis & Recommendation
    • 14.4.1. Agilent Technologies, Inc.
    • 14.4.2. Thermo Fisher Scientific Inc.
    • 14.4.3. Illumina, Inc.
    • 14.4.4. F. Hoffmann-La Roche AG

Companies Mentioned

  • 1. 10x Genomics, Inc.
  • 2. 23andMe Holding Co.
  • 3. Agilent Technologies, Inc.
  • 4. BGI Genomics Co., Ltd.
  • 5. Bio-Rad Laboratories, Inc.
  • 6. Centogene N.V.
  • 7. EPIC Sciences, Inc.
  • 8. Eurofins Scientific SE
  • 9. F. Hoffmann-La Roche Ltd.
  • 10. GE Healthcare (Now Cytiva) by Danaher Corporation
  • 11. Gencove, Inc.
  • 12. GenScript Biotech Corporation
  • 13. Guardant Health, Inc.
  • 14. Helix OpCo, LLC
  • 15. Illumina, Inc.
  • 16. Invitae Corporation
  • 17. Merck & Co., Inc.
  • 18. Myriad Genetics Laboratories, Inc.
  • 19. Natera, Inc.
  • 20. Oxford Nanopore Technologies PLC
  • 21. Pacific Biosciences of California, Inc.
  • 22. Personalis, Inc.
  • 23. Quest Diagnostics
  • 24. SomaLogic, Inc.
  • 25. Sophia Genetics SA
  • 26. Thermo Fisher Scientific Inc.
  • 27. Twist Bioscience Corporation

LIST OF FIGURES

  • FIGURE 1. GENOMICS MARKET MULTI-CURRENCY
  • FIGURE 2. GENOMICS MARKET MULTI-LANGUAGE
  • FIGURE 3. GENOMICS MARKET RESEARCH PROCESS
  • FIGURE 4. GENOMICS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENOMICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENOMICS MARKET SIZE, BY OFFERING, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL GENOMICS MARKET SIZE, BY OFFERING, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GENOMICS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL GENOMICS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GENOMICS MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL GENOMICS MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL GENOMICS MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL GENOMICS MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES GENOMICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES GENOMICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. GENOMICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. GENOMICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GENOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENOMICS MARKET DYNAMICS
  • TABLE 7. GLOBAL GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENOMICS MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENOMICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENOMICS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENOMICS MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENOMICS MARKET SIZE, BY SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENOMICS MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENOMICS MARKET SIZE, BY TALENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENOMICS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GENOMICS MARKET SIZE, BY CELLULAR MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENOMICS MARKET SIZE, BY DNA MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GENOMICS MARKET SIZE, BY PROTEIN MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GENOMICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GENOMICS MARKET SIZE, BY END-POINT PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GENOMICS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GENOMICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GENOMICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GENOMICS MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL GENOMICS MARKET SIZE, BY EPIGENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL GENOMICS MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL GENOMICS MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL GENOMICS MARKET SIZE, BY STRUCTURAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL GENOMICS MARKET SIZE, BY ANIMAL GENETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL GENOMICS MARKET SIZE, BY CROP DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL GENOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL GENOMICS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL GENOMICS MARKET SIZE, BY AGRIBUSINESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL GENOMICS MARKET SIZE, BY LIVESTOCK COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL GENOMICS MARKET SIZE, BY SEED COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL GENOMICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 106. CANADA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 108. MEXICO GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 109. MEXICO GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 110. MEXICO GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 118. MEXICO GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 119. UNITED STATES GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 120. UNITED STATES GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 121. UNITED STATES GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 122. UNITED STATES GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES GENOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. AUSTRALIA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 148. AUSTRALIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 150. AUSTRALIA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. AUSTRALIA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. AUSTRALIA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 157. CHINA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 158. CHINA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 159. CHINA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 160. CHINA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. CHINA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 162. CHINA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. CHINA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. CHINA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. CHINA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. CHINA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 167. CHINA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 168. CHINA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 169. INDIA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 170. INDIA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 171. INDIA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 172. INDIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. INDIA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 174. INDIA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. INDIA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. INDIA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. INDIA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. INDIA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 179. INDIA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 180. INDIA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 181. INDONESIA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 182. INDONESIA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 183. INDONESIA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 184. INDONESIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. INDONESIA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 186. INDONESIA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. INDONESIA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. INDONESIA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. INDONESIA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. INDONESIA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 191. INDONESIA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 192. INDONESIA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 193. JAPAN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 194. JAPAN GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 195. JAPAN GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 196. JAPAN GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. JAPAN GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 198. JAPAN GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 199. JAPAN GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. JAPAN GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 201. JAPAN GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. JAPAN GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 203. JAPAN GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 204. JAPAN GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 205. MALAYSIA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 206. MALAYSIA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 207. MALAYSIA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 208. MALAYSIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. MALAYSIA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 210. MALAYSIA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. MALAYSIA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. MALAYSIA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. MALAYSIA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. MALAYSIA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 215. MALAYSIA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 216. MALAYSIA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 218. PHILIPPINES GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 220. PHILIPPINES GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 222. PHILIPPINES GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. PHILIPPINES GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. PHILIPPINES GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 228. PHILIPPINES GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 229. SINGAPORE GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 230. SINGAPORE GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 231. SINGAPORE GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 232. SINGAPORE GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. SINGAPORE GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 234. SINGAPORE GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. SINGAPORE GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 236. SINGAPORE GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. SINGAPORE GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SINGAPORE GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 239. SINGAPORE GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 240. SINGAPORE GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH KOREA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH KOREA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH KOREA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH KOREA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH KOREA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 252. SOUTH KOREA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 253. TAIWAN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 254. TAIWAN GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 255. TAIWAN GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 256. TAIWAN GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 257. TAIWAN GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 258. TAIWAN GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 259. TAIWAN GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 260. TAIWAN GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 261. TAIWAN GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. TAIWAN GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 263. TAIWAN GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 264. TAIWAN GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 265. THAILAND GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 266. THAILAND GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 267. THAILAND GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 268. THAILAND GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 269. THAILAND GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 270. THAILAND GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 271. THAILAND GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 272. THAILAND GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 273. THAILAND GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. THAILAND GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 275. THAILAND GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 276. THAILAND GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 277. VIETNAM GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 278. VIETNAM GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 279. VIETNAM GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 280. VIETNAM GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 281. VIETNAM GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 282. VIETNAM GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 283. VIETNAM GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 284. VIETNAM GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 285. VIETNAM GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. VIETNAM GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 287. VIETNAM GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 288. VIETNAM GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 302. DENMARK GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 303. DENMARK GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 304. DENMARK GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 305. DENMARK GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 306. DENMARK GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 307. DENMARK GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 308. DENMARK GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 309. DENMARK GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 310. DENMARK GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. DENMARK GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 312. DENMARK GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 313. DENMARK GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 314. EGYPT GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 315. EGYPT GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 316. EGYPT GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 317. EGYPT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 318. EGYPT GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 319. EGYPT GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 320. EGYPT GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 321. EGYPT GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 322. EGYPT GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 323. EGYPT GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 324. EGYPT GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 325. EGYPT GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 326. FINLAND GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 327. FINLAND GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 328. FINLAND GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 329. FINLAND GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 330. FINLAND GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 331. FINLAND GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 332. FINLAND GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 333. FINLAND GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 334. FINLAND GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 335. FINLAND GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 336. FINLAND GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 337. FINLAND GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 338. FRANCE GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 339. FRANCE GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 340. FRANCE GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 341. FRANCE GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 342. FRANCE GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 343. FRANCE GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 344. FRANCE GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 345. FRANCE GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 346. FRANCE GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 347. FRANCE GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 348. FRANCE GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 349. FRANCE GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 350. GERMANY GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 351. GERMANY GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 352. GERMANY GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 353. GERMANY GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 354. GERMANY GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 355. GERMANY GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 356. GERMANY GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 357. GERMANY GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 358. GERMANY GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 359. GERMANY GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 360. GERMANY GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 361. GERMANY GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 362. ISRAEL GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 363. ISRAEL GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 364. ISRAEL GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 365. ISRAEL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 366. ISRAEL GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 367. ISRAEL GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 368. ISRAEL GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 369. ISRAEL GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 370. ISRAEL GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 371. ISRAEL GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 372. ISRAEL GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 373. ISRAEL GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 374. ITALY GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 375. ITALY GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 376. ITALY GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 377. ITALY GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 378. ITALY GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 379. ITALY GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 380. ITALY GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 381. ITALY GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 382. ITALY GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 383. ITALY GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 384. ITALY GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 385. ITALY GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 386. NETHERLANDS GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 387. NETHERLANDS GENOMICS MARKET SIZE, BY CONSUMABLES,